AIS
ATNM icon

AM Investment Strategies’s Actinium Pharmaceuticals ATNM Stock Holding History

AM Investment Strategies’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Hold
29,356
– – 0.01% 113
2026
Q1 		$29K Hold
29,356
– – 0.01% 110
2025
Q4 		$40K Buy
+29,356
New +$42.8K 0.01% 115
2025
Q3 		– Sell
-30,872
Closed -$43K – 111
2025
Q2 		$43K Hold
30,872
– – 0.01% 107
2025
Q1 		$50K Buy
30,872
+16,450
+114% +$20.9K 0.01% 105
2024
Q4 		$18K Hold
14,422
– – ﹤0.01% 100
2024
Q3 		$27K Buy
14,422
+840
+6% +$3.32K 0.01% 104
2024
Q2 		$101K Buy
13,582
+1,000
+8% +$8.23K 0.02% 105
2024
Q1 		$99K Buy
+12,582
New +$80.9K 0.03% 107

Other funds holding ATNM

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
PAI
Pittenger & Anderson Inc Lincoin, Nebraska $2.79B AUM 12.81% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM

AM Investment Strategies's ATNM Position: Q2 2026 in Review

AM Investment Strategies held its Actinium Pharmaceuticals (ATNM) position steady in Q2 2026 at 29,356 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #113.

AM Investment Strategies first reported a position in ATNM in Q1 2024 and has held it in 9 quarters since. The position peaked at $101K in Q2 2024. 5 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • AM Investment Strategies held 29,356 shares of Actinium Pharmaceuticals worth $29K as of Q2 2026.
  • AM Investment Strategies left its Actinium Pharmaceuticals share count unchanged in Q2 2026.
  • Actinium Pharmaceuticals made up 0.01% of AM Investment Strategies's portfolio in Q2 2026, its #113 holding.
  • AM Investment Strategies first reported a position in Actinium Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • AM Investment Strategies's Actinium Pharmaceuticals position peaked at $101K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on AM Investment Strategies's 13F filing for Q2 2026, filed 16 Jul 2026.